Spectral Medical (EDTXF) Stock Price, News & Analysis

Company Overview

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.48 to $0.48
• 50-Day Range: $0.34 to $0.53
• 52-Week Range: $0.29 to $0.55
• Volume: 2,000 shs
• Average Volume: 14,703 shs
• Market Capitalization: $136.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Spectral Medical Stock Analysis - MarketRank™

Spectral Medical scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Spectral Medical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Spectral Medical is -6.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Spectral Medical is -6.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.03% of the float of Spectral Medical has been sold short.

Short Interest Ratio / Days to Cover

Spectral Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Spectral Medical has recently increased by 5.52%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Spectral Medical does not currently pay a dividend.

Dividend Growth

Spectral Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.03% of the float of Spectral Medical has been sold short.

Short Interest Ratio / Days to Cover

Spectral Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Spectral Medical has recently increased by 5.52%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.31

News Sentiment

Spectral Medical has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Spectral Medical this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Spectral Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.50% of the stock of Spectral Medical is held by insiders.

EDTXF Stock Analysis - Frequently Asked Questions

How have EDTXF shares performed this year?

Spectral Medical's stock was trading at $0.3474 at the beginning of 2025. Since then, EDTXF shares have increased by 37.5% and is now trading at $0.4777.
View the best growth stocks for 2025 here.

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc. (OTCMKTS:EDTXF) announced its earnings results on Friday, November, 8th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $0.37 million for the quarter.

How do I buy shares of Spectral Medical?

Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/08/2024
• Today: 3/12/2025
• Next Earnings (Estimated): 3/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EDTXF
• Previous Symbol: OTCMKTS:DIAGF
• CIK: N/A
• Web: www.spectraldx.com
• Phone: (416) 626-3233
• Fax: 416-626-7383
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-11,600,000.00
• Net Margins: -1,245.87%
• Pretax Margin: -1,248.98%
• Return on Equity: N/A
• Return on Assets: -351.89%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.22
• Quick Ratio: 0.21

Sales & Book Value

• Annual Sales: $1.18 million
• Price / Sales: 115.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -11.94

Miscellaneous

• Outstanding Shares: 284,748,000
• Free Float: 280,477,000
• Market Cap: $136.02 million
• Optionable: Not Optionable
• Beta: 0.83